About the Authors

Sunny R. Slone

Affiliation Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

Mathieu Lesort

Affiliation Department of Psychiatry, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

Talene A. Yacoubian

tyacoub@uab.edu

Affiliation Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

Competing Interests

Sunny Slone and Mathieu Lesort have no conflicts of interest to declare. Talene Yacoubian has read the journal's policy and declares that she has a US Patent # 7,919,262 on the use of 14-3-3s in neurodegeneration. This does not alter the authors' adherence to all the PloS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: TAY ML. Performed the experiments: SRS ML TAY. Analyzed the data: SRS TAY. Contributed reagents/materials/analysis tools: SRS ML TAY. Wrote the paper: TAY.